William Grossman is Chief Medical Officer at Arcus Biosciences, Inc. (RCUS). They have made 7 open-market trades across 2 companies since 2019, most recently 2026-09-22.
CIK 0001730229
3 open-market purchases totalling $17K since 2019, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RCUS | 24,614 | $545K |
| BLCM | 26,874 | $25K |
| ENGN | 5,102 | $8K |
| Total | $579K |
Shares reported on the most recent Form 4, priced at the 2026-09-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENGN | BUY | 2026-09-22 | 2026-09-24 | $1.97 | $10K | -5.5% | — | — |
| RCUS | SELL | 2021-06-16 | 2021-06-21 | $23.89 | $334K | +19.0% | +37.1% | +51.7% |
| RCUS | SELL | 2021-04-23 | 2021-04-26 | $31.37 | $259K | -17.2% | -32.7% | -10.2% |
| RCUS | SELL | 2021-03-16 | 2021-03-18 | $35.03 | $149K | -20.5% | -9.2% | -32.0% |
| RCUS | SELL | 2020-12-16 | 2020-12-18 | $31.35 | $133K | -16.6% | +18.1% | +13.5% |
| RCUS | BUY | 2020-07-31 | 2020-08-04 | $19.73 | $4K | +11.3% | -1.9% | -1.6% |
| RCUS | BUY | 2019-10-10 | 2019-10-15 | $8.00 | $3K | -0.4% | -2.2% | +22.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.